#United Kingdom #MatOrtho #ReCerf #Leatherhead #Hip Replacement

MatOrtho’s Revolutionary ReCerf® Hip Prosthesis

On December 3, 2024, MatOrtho, a leading innovator in hip and knee replacement technologies, announced a significant milestone in orthopedic surgery with the approval of the ReCerf® hip prosthesis by Australia’s Therapeutic Goods Administration (TGA). This makes ReCerf® the world’s first fully ceramic hip replacement system to receive such regulatory clearance, marking a pivotal moment for joint replacement technology and overall patient care.

A Leap Forward in Orthopedic Solutions

Oriol Millet-Lopez, the Interim CEO of MatOrtho, remarked on this achievement, stating that it represents not just a success for the company, but for orthopedic surgery as a whole. The ReCerf® system embodies years of dedicated innovation aimed at improving patient outcomes. According to Millet-Lopez, the TGA approval highlights the remarkable early performance of the prosthesis, with immense potential to redefine hip replacement procedures globally.

Exceptional Clinical Outcomes

Since its introduction in September 2018, the ReCerf® hip prosthesis has demonstrated extraordinary results for more than 1,200 patients who have undergone the procedure. Compared to traditional hip replacements and previously existing implants, ReCerf® patients have seen a significantly lower rate of reoperations. Moreover, many of these patients, including a notable number of younger individuals involved in high-level sports, have been able to resume their active lifestyles without limitations. A report from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) noted an astounding revision rate of just 0.3% after three years of using the ReCerf® system, providing strong evidence of its reliability and effectiveness.

A Global Achievement with Far-reaching Impact

The TGA approval of ReCerf® stands as the first of its kind worldwide, paving the way for advancements in hip replacement technology. MatOrtho is actively collaborating with the Australian Prosthesis List Advisory Committee (PLAC) to ensure the inclusion of ReCerf® on the upcoming prosthesis list. Furthermore, the company is pursuing regulatory approvals in other critical markets to extend the benefits of ceramic hip replacements to an even broader range of patients.

Mike Tuke, the founder of MatOrtho, highlighted the advantages of the ReCerf®’s unique ceramic composition, labeling it a solution that alleviates concerns related to metal implants. By allowing surgeons to preserve more of the natural hip structure, the ReCerf® can potentially eliminate the need for conventional stemmed hip replacements. This feature significantly appeals to those specializing in the sophisticated technique of hip resurfacing, ensuring both surgeons and patients can trust in a product developed by a company renowned as the cradle of modern hip replacement technology.

Looking Ahead

The development of ReCerf® is the result of over a decade’s worth of research and development at MatOrtho, combining clinical insights with advanced materials. The TGA’s endorsement signifies a turning point in the industry, promising a superior, long-lasting, and patient-centered approach to hip surgeries. For further insights into the ReCerf® hip prosthesis and MatOrtho’s commitment to orthopedic innovations, visit www.recerf.com.

Contact Information

For media inquiries, reach out to:

• - Name: Dr. Michael Watson, PhD MCIM
• - Title: Senior Product Manager
• - Company: MatOrtho
• - Phone: 01372 224200
• - Email: [email protected]
• - Website: www.MatOrtho.com

As a world leader in orthopedic innovation, MatOrtho is devoted to developing hip and knee replacement technologies that aim to enhance patient outcomes and set new industry standards.